methylphenidate has been researched along with Heart Diseases in 3 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.
Excerpt | Relevance | Reference |
---|---|---|
" Despite their efficacy and long history of use, there is concern about their potential for adverse cardiovascular effects in children and adolescents." | 1.36 | Cardiovascular safety of stimulant medications for pediatric attention-deficit hyperactivity disorder. ( Muniz, R; Silva, RR; Skimming, JW, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Silva, RR | 1 |
Skimming, JW | 1 |
Muniz, R | 1 |
Kaufmann, MW | 1 |
Cassem, N | 1 |
Murray, G | 1 |
MacDonald, D | 1 |
3 other studies available for methylphenidate and Heart Diseases
Article | Year |
---|---|
Cardiovascular safety of stimulant medications for pediatric attention-deficit hyperactivity disorder.
Topics: Adolescent; Adult; Amphetamines; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Card | 2010 |
Methylphenidate: cardiac risks.
Topics: Central Nervous System Stimulants; Heart Diseases; Humans; Methylphenidate; Mortality | 2006 |
The use of methylphenidate in depressed patients after cardiac surgery.
Topics: Aged; Depressive Disorder; Female; Heart Diseases; Humans; Male; Methylphenidate; Middle Aged; Posto | 1984 |